| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 1.695 | 8.316 | 52.773 | 50.788 | 39.376 | 25.702 | 54.080 | 11.716 | 7.149 |
| Total Income - EUR | - | 1.695 | 8.316 | 52.773 | 50.788 | 39.396 | 25.720 | 54.111 | 11.773 | 7.180 |
| Total Expenses - EUR | - | 848 | 1.210 | 1.446 | 1.432 | 1.377 | 1.367 | 1.623 | 1.788 | 1.736 |
| Gross Profit/Loss - EUR | - | 846 | 7.106 | 51.328 | 49.356 | 38.018 | 24.353 | 52.487 | 9.985 | 5.444 |
| Net Profit/Loss - EUR | - | 795 | 6.857 | 49.744 | 47.832 | 36.937 | 23.597 | 50.897 | 8.419 | 4.634 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Oncosuport Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13 |
| Current Assets | - | 1.670 | 9.760 | 50.740 | 51.091 | 37.498 | 25.526 | 53.438 | 12.464 | 8.831 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 460 | 9.057 | 3.496 | 3.507 | 1.769 | 45.418 | 7.601 | 4.922 |
| Cash | - | 1.670 | 9.300 | 41.682 | 47.595 | 33.991 | 23.757 | 8.020 | 4.863 | 3.910 |
| Shareholders Funds | - | 840 | 7.682 | 49.796 | 47.882 | 36.986 | 23.645 | 50.946 | 8.468 | 4.682 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 830 | 2.077 | 944 | 3.209 | 512 | 1.881 | 2.492 | 3.996 | 4.162 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oncosuport Srl